Health Canada reviewed the risk of potential serious muscle-related side effects with finasteride use because of reports in which these events were seen in patients treated with Propecia and Proscar. The safety review focussed on potential risks of serious muscle-related adverse events such as rhabdomyolysis (pain in muscles with breakdown of muscle tissue and an increase in certain muscle proteins known as creatine kinase [CK] enzymes, myopathy (disease of muscles with pain and an increase in CK enzymes) and muscle disorders such as pain, weakness, atrophy (wasting) or stiffness.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
Similar records